1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology in Japan

Biotechnology in Japan

  • January 2016
  • -
  • MarketLine
  • -
  • 36 pages

Introduction

Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Japan biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

- The Japanese biotechnology market is expected to generate total revenues of $35.6bn in 2015, representing a compound annual growth rate (CAGR) of 3.4% between 2011 and 2015.

- The environment & industrial processing segment is expected to be the market's most lucrative in 2015, with total revenues of $12.2bn, equivalent to 34.3% of the market's overall value.

- The Japanese government has invested significantly in the biotech industry, partly in response to China’s aim of overtaking Japan as a regional center for the industry. In 2014, the government set aside approximately $165bn for cancer initiatives as well as further investment in the creation of a pilot factory for biologic drugs.

Features

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Japan

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Japan

- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Japan biotechnology market with five year forecasts

- Macroeconomic indicators provide insight into general trends within the Japan economy

Key Questions Answered

- What was the size of the Japan biotechnology market by value in 2015?

- What will be the size of the Japan biotechnology market in 2020?

- What factors are affecting the strength of competition in the Japan biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up Japan's biotechnology market?

Table Of Contents

Biotechnology in Japan
TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Geography segmentation 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Summary 12
Buyer power 13
Supplier power 14
New entrants 15
Threat of substitutes 17
Degree of rivalry 18
Leading Companies 19
Astellas Pharma Inc. 19
Daiichi Sankyo Co., Ltd. 22
Mitsubishi Tanabe Pharma Corporation 25
Takeda Pharmaceutical Company Limited 28
Macroeconomic Indicators 31
Country Data 31
Methodology 33
Industry associations 34
Related MarketLine research 34
Appendix 35
About MarketLine 35

List of Tables
Table 1: Japan biotechnology industry value: $ billion, 2011-15(e)
Table 2: Japan biotechnology industry category segmentation: $ billion, 2015(e)
Table 3: Japan biotechnology industry geography segmentation: $ billion, 2015(e)
Table 4: Japan biotechnology industry value forecast: $ billion, 2015-20
Table 5: Astellas Pharma Inc.: key facts
Table 6: Astellas Pharma Inc.: key financials ($)
Table 7: Astellas Pharma Inc.: key financials (Â¥)
Table 8: Astellas Pharma Inc.: key financial ratios
Table 9: Daiichi Sankyo Co., Ltd.: key facts
Table 10: Daiichi Sankyo Co., Ltd.: key financials ($)
Table 11: Daiichi Sankyo Co., Ltd.: key financials (Â¥)
Table 12: Daiichi Sankyo Co., Ltd.: key financial ratios
Table 13: Mitsubishi Tanabe Pharma Corporation: key facts
Table 14: Mitsubishi Tanabe Pharma Corporation: key financials ($)
Table 15: Mitsubishi Tanabe Pharma Corporation: key financials (Â¥)
Table 16: Mitsubishi Tanabe Pharma Corporation: key financial ratios
Table 17: Takeda Pharmaceutical Company Limited: key facts
Table 18: Takeda Pharmaceutical Company Limited: key financials ($)
Table 19: Takeda Pharmaceutical Company Limited: key financials (Â¥)
Table 20: Takeda Pharmaceutical Company Limited: key financial ratios
Table 21: Japan size of population (million), 2011-15
Table 22: Japan gdp (constant 2005 prices, $ billion), 2011-15
Table 23: Japan gdp (current prices, $ billion), 2011-15
Table 24: Japan inflation, 2011-15
Table 25: Japan consumer price index (absolute), 2011-15
Table 26: Japan exchange rate, 2011-15

List of Figures
Figure 1: Japan biotechnology industry value: $ billion, 2011-15(e)
Figure 2: Japan biotechnology industry category segmentation: % share, by value, 2015(e)
Figure 3: Japan biotechnology industry geography segmentation: % share, by value, 2015(e)
Figure 4: Japan biotechnology industry value forecast: $ billion, 2015-20
Figure 5: Forces driving competition in the biotechnology industry in Japan, 2015
Figure 6: Drivers of buyer power in the biotechnology industry in Japan, 2015
Figure 7: Drivers of supplier power in the biotechnology industry in Japan, 2015
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Japan, 2015
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Japan, 2015
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Japan, 2015
Figure 11: Astellas Pharma Inc.: revenues and profitability
Figure 12: Astellas Pharma Inc.: assets and liabilities
Figure 13: Daiichi Sankyo Co., Ltd.: revenues and profitability
Figure 14: Daiichi Sankyo Co., Ltd.: assets and liabilities
Figure 15: Mitsubishi Tanabe Pharma Corporation: revenues and profitability
Figure 16: Mitsubishi Tanabe Pharma Corporation: assets and liabilities
Figure 17: Takeda Pharmaceutical Company Limited: revenues and profitability
Figure 18: Takeda Pharmaceutical Company Limited: assets and liabilities

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Sample Preparation Market by Product , Consumables ), Application , End Users  - Global Forecast to 2021

Sample Preparation Market by Product , Consumables ), Application , End Users - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • June 2016
  • by MarketsandMarkets

The sample preparation market is poised to reach USD 7,203.2 million by 2021 from USD 5,512.2 in 2016, growing at a CAGR of 5.5% during the forecast period of 2016 to 2021. Sample preparation involves ...

Cell Expansion Market by Product , Cell Type , Application , End user  - Global Forecasts to 2021

Cell Expansion Market by Product , Cell Type , Application , End user - Global Forecasts to 2021

  • $ 5 650
  • Industry report
  • June 2016
  • by MarketsandMarkets

The cell expansion market is expected to reach USD 18.76 billion by 2021 from USD 8.34 billion in 2016 at a CAGR of 17.6%. The global cell expansion market is segmented based on product, cell type, application, ...

3D Cell Culture Market by Technology, Application, End-Users and Geography- Global Forecast to 2021

3D Cell Culture Market by Technology, Application, End-Users and Geography- Global Forecast to 2021

  • $ 5 650
  • Industry report
  • July 2016
  • by MarketsandMarkets

The global 3D cell culture market size is expected to reach USD 1345.2 million by 2021 from USD 466.8 million in 2016, at a CAGR of 23.6%. The global 3D cell culture market is segmented based on technology, ...

Trends In Gene Therapy

July 2016 $ 5 000

Download Unlimited Documents from Trusted Public Sources

Plant Biotechnology Markets in Mexico

  • September 2016
  • Plant Biotechno...  

    Honey  

    Soybean  

  • Mexico  

    Argentina  

View report >

Genomics Industry in the US

  • September 2016
    49 pages
  • DNA  

    DNA Sequencing  

    Genome Sequenci...  

  • United States  

View report >

Influenza Statistics in Europe

  • September 2016
    60 pages
  • Infectious Dise...  

    Influenza  

    Vaccine  

  • Europe  

    Romania  

    United Kingdom  

View report >

Global Dna Supply

16 days ago

Related Market Segments :

Biotechnology
Pharmaceutical

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.